Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Topical formulation 2022-9-28 2022-10-27
Anti-egfr antibodies and antibody drug conjugates 2022-8-24 2022-10-01
Methods for treating HCV 2022-7-29 2022-8-25
Anti-cmet antibody drug conjugates and methods for their use 2022-6-20 2022-8-01
Anti-CD40 antibodies and uses thereof 2022-6-10 2022-6-30
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[ … 2022-5-27 2022-9-22
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]-PYRAZIN-8 … 2022-5-27 2022-9-29
Isolation and purification of anti-il-13 antibodies using protein a affinity … 2022-5-17 2022-10-27
Medication packaging and dispensing system 2022-5-10 2022-8-25
Methods of treatment of diseases in which il-13 activity is detrimental using … 2022-5-10 2022-9-08
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[ … 2022-5-02 2022-8-25
Methods of treating crohn's disease and ulcerative colitis 2022-4-28 2022-9-01
Macrocyclic mcl-1 inhibitors and methods of use 2022-4-22 2022-8-18
Elagolix Sodium Compositions and Processes 2022-4-14 2022-10-13
Cocrystals of upadacitinib 2022-4-07 2022-10-13
Methods of treatment of non-small-cell lung carcinoma using telisotuzumab … 2022-4-06 2022-10-13
ANTI-RGMa (REPULSIVE GUIDANCE MOLECULE A) ANTAGONISTIC ANTIBODIES FOR TREATING … 2022-4-06 2022-6-21
Methods of treating crohn's disease and ulcerative colitis 2022-4-01 2022-7-28
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 … 2022-3-30 2022-8-25
Enzyme compositions with reduced viral and microbial contamination 2022-3-21 2022-7-07
Monoclonal antibodies against amyloid beta protein and uses thereof 2022-3-08 2022-6-21
Anti-egfr antibody drug conjugates 2022-3-02 2022-5-01
System and method of multi-drug delivery 2022-2-27 2022-4-01
Monoclonal antibodies against amyloid beta protein and uses thereof 2022-2-24 2022-3-17
Anti-cd40 antibodies and their uses 2022-2-18 2022-5-09
BROMODOMAIN INHIBITORS 2022-2-14 2022-3-31
Modulators of the integrated stress pathway 2022-2-11 2022-3-03
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[ … 2022-2-09 2022-9-08
Methods of administrating elagolix 2022-1-28 2022-8-04
Systems and methods for identifying protein aggregates in biotherapeutics 2022-1-25 2022-10-13
Composition and method for the diagnosis and treatment of iron-related … 2022-1-24 2022-2-17
Anti-egfr antibody-drug conjugates 2022-1-20 2022-7-28
Methods of treating crohn's disease and ulcerative colitis 2022-1-06 2022-8-18
Extended release upadacitinib formulations 2021-12-29 2022-7-07
Anti-ox40 antibodies and their uses 2021-12-23 2022-4-14
Composition and method for diagnosis and treatment of diseases associated with … 2021-12-22 2022-1-27
Bicyclic pyrazole bruton's tyrosine kinase inhibitors 2021-12-16 2022-6-23
MODULATORS OF THE INTEGRATED STRESS PATHWAY 2021-11-30 2021-12-30
Automatic injection device 2021-11-19 2022-10-06
Glucocorticoid receptor agonist and immunoconjugates thereof 2021-11-19 2021-12-16
Methods of treating heavy menstrual bleeding 2021-11-18 2022-3-17
Bromodomain inhibitor 2021-11-10 2022-2-08
Monoclonal antibodies against rgm a protein and uses thereof 2021-11-05 2022-3-08
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune … 2021-11-03 2022-10-06
MODULATORS OF THE INTEGRATED STRESS PATHWAY 2021-11-01 2022-5-31
Bispecific binding molecules 2021-11-01 2022-9-29
Substituted cyclolakyls as modulators of the integrated stress pathway 2021-10-28 2021-12-01
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune … 2021-10-17 2021-12-01
PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USING THEM 2021-10-13 2021-11-30
Solid pharmaceutical compositions for treating hcv 2021-10-06 2021-12-01
Interleukin-22 (il-22) fusion proteins and uses thereof 2021-10-01 2022-4-07
Methods for Treating HCV 2021-9-24 2022-9-15
Nuclear receptor modulators 2021-9-15 2021-10-14
Prodrug modulators of the integrated stress pathway 2021-9-02 2022-8-11
Carbidopa and l-dopa prodrugs and methods of use 2021-8-31 2022-1-04
Anti-VEGF/DLL4 dual variable domain immunoglobulins and uses thereof 2021-8-24 2021-9-16
Methods for treating relapsing forms of multiple sclerosis 2021-8-19 2021-12-02
Abt-165 in combination with folinic acid, 5-fluorouracil, and irinotecan for … 2021-8-17 2022-7-07
Carbidopa and l-dopa prodrugs and methods of using the same 2021-8-16 2021-12-02
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms … 2021-8-06 2022-3-10
Anti-αlpha-4-βeta-7 antibodies 2021-7-16 2022-5-01
Antibody drug conjugates with cell permeable Bcl-xL inhibitors 2021-7-15 2021-8-12
Wearable automatic injection system and apparatus 2021-6-29 2021-10-14
Methods of administering elagolix 2021-6-18 2021-7-15
Glucocorticoid receptor agonist and immunoconjugates thereof 2021-6-09 2021-9-03
Combination of two antivirals for treating hepatitis c 2021-6-07 2021-9-09
Solid dispersions containing an apoptosis-inducing agent 2021-6-07 2022-4-28
Modulators of integrated stress pathway 2021-5-18 2021-9-16
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis 2021-5-13 2021-11-18
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis 2021-5-13 2021-11-18
Medicine container, method of assembling the container, and method of … 2021-5-13 2022-1-13
Anti-hemojuvelin (HJV) antibodies for treating anemia of chronic disease 2021-5-13 2021-11-18
Anti-hemojuvelin (hjv) antibodies for treating anemia of chronic disease 2021-5-13 2021-11-18
Prolactin receptor binding proteins and uses thereof 2021-5-10 2021-6-03
Automatic injection device 2021-5-03 2022-3-24
Pharmaceutical formulations for subcutaneous administration 2021-5-02 2021-6-30
Bcl xl inhibitory compounds having low cell permeability and antibody drug … 2021-4-22 2021-6-30
ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES 2021-4-16 2022-1-20
Modulator of integrated stress pathway 2021-4-13 2021-7-29
Methods of treating diabetic kidney disease 2021-4-12 2021-10-14
Methods of treating diabetic kidney disease 2021-4-12 2021-10-14
Crystalline forms of an apoptosis-inducing agent 2021-4-09 2021-10-14
Crystal forms 2021-3-23 2021-8-05
Primary carboxamides as BTK inhibitors 2021-3-08 2021-3-25
Bromodomain inhibitors 2021-3-05 2021-7-15
Bromodomain inhibitors 2021-3-04 2021-7-15
Wearable automatic injection device for controlled administration of … 2021-3-01 2022-1-27
Trispecific binding molecules 2021-2-17 2021-12-16
Glucocorticoid receptor agonist and immunoconjugates thereof 2021-2-12 2021-8-19
Anti-b7-h3 antibodies and antibody drug conjugates 2021-2-02 2021-3-19
Dosing regimens for elagolix 2021-1-29 2021-3-25
Protein tyrosine phosphatase inhibitors and their methods of use 2021-1-19 2021-7-19
THERAPEUTIC PROTEINS BINDING TO DLL4 2021-1-18 2021-2-26
Syringe with two-stage sealing pressure 2021-1-15 2021-12-09
Protein formulations and methods of making same 2020-12-29 2021-4-22
Levodopa and carbidopa intestinal gel and methods of use 2020-12-24 2021-5-13
Protein tyrosine phosphatase degraders and methods of use thereof 2020-12-21 2021-10-01
Method for treating hepatitis c 2020-12-21 2021-4-08
PROTEIN TYROSINE PHOSPHATASE DEGRADATORS AND METHODS OF USE OF SUCH 2020-12-21 2022-3-23
Protein tyrosine phosphatase inhibitors and methods of use thereof 2020-12-18 2022-10-26